JSW Cement (JSWCEMENT) Q4 20/21 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 20/21 earnings summary
14 Oct, 2026Executive summary
FY 2020-21 recovery strengthened in H2 after pandemic shutdowns; consolidated sales reached a record 8.01 MMT, up 7.1% YoY, and capacity utilisation averaged 57% vs 54% in FY20.
Consolidated revenue rose 32% to ₹3,858.15 crore, EBITDA increased 36% to ₹818.73 crore, and PAT grew 62% to ₹249.85 crore.
Growth strategy centres on expanding capacity from 14 MTPA to 25 MTPA, premium products, operating efficiency and sustainable cement.
Financial highlights
Consolidated revenue ₹3,858.15 crore vs ₹2,927.51 crore; operating EBITDA ₹818.73 crore vs ₹601.81 crore; PAT ₹249.85 crore vs ₹154.31 crore in FY20.
Consolidated production was 7.92 MTPA, up 4.8% YoY; sales were 8.01 MTPA, up 7.1%.
Standalone revenue was ₹3,413.01 crore, up 23.6%; operating EBITDA ₹783.32 crore, up 32.4%; PAT ₹257.85 crore vs ₹161.75 crore.
Consolidated PBT was ₹379.48 crore; excluding the ₹35.40 crore exceptional ESOP charge, PBT before exceptional item was ₹414.88 crore.
Outlook and guidance
Capacity target is 25 MTPA by FY 2024-25, with plans for ~11 MTPA of grinding and 2.1 MTPA of clinker capacity across eastern, western and southern India.
Near-term projects include 0.8 MTPA grinding at Vijayanagar, 1.2 MTPA at Salboni and 0.8 MTPA at Salem; debottlenecking and clinker upgrades are also underway.
Management expects cement demand to benefit from infrastructure spending, affordable housing and rural construction; industry production was projected to grow 4–7% in FY 2021-22.
Latest events from JSW Cement
- Expansion and IPO plans advance as pricing pressure drives a consolidated FY25 loss.JSWCEMENT
Q4 24/25 - Volume and capacity surged, but lower PAT and expansion financing needs remain pivotal.JSWCEMENT
Q4 23/24 - Volume growth and aggressive capacity expansion, despite compressed earnings and rising costs.JSWCEMENT
Q4 22/23 - Revenue and volumes grew, but fuel inflation compressed EBITDA as expansion accelerated.JSWCEMENT
Q4 21/22 - Higher EBITDA and premium mix offset disruption as capacity expanded to 14 MTPA.JSWCEMENT
Q4 19/20 - Sales surged 43%, but lower reported profit and expansion debt mark FY2019.JSWCEMENT
Q4 18/19 - Record sales and capacity expansion lifted growth, but costs and lower standalone profit tempered FY18.JSWCEMENT
Q4 17/18 - Record FY17 earnings and volumes funded an ambitious capacity expansion plan.JSWCEMENT
Q4 16/17 - Sales growth and an 85% EBITDA increase drove a return to FY16 profitability.JSWCEMENT
Q4 15/16